Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Int J Mol Sci ; 22(22)2021 Nov 19.
Article in English | MEDLINE | ID: mdl-34830380

ABSTRACT

Three decades of research have documented the spatiotemporal dynamics of RHO family GTPase membrane extraction regulated by guanine nucleotide dissociation inhibitors (GDIs), but the interplay of the kinetic mechanism and structural specificity of these interactions is as yet unresolved. To address this, we reconstituted the GDI-controlled spatial segregation of geranylgeranylated RHO protein RAC1 in vitro. Various biochemical and biophysical measurements provided unprecedented mechanistic details for GDI function with respect to RHO protein dynamics. We determined that membrane extraction of RHO GTPases by GDI occurs via a 3-step mechanism: (1) GDI non-specifically associates with the switch regions of the RHO GTPases; (2) an electrostatic switch determines the interaction specificity between the C-terminal polybasic region of RHO GTPases and two distinct negatively-charged clusters of GDI1; (3) a non-specific displacement of geranylgeranyl moiety from the membrane sequesters it into a hydrophobic cleft, effectively shielding it from the aqueous milieu. This study substantially extends the model for the mechanism of GDI-regulated RHO GTPase extraction from the membrane, and could have implications for clinical studies and drug development.


Subject(s)
Prenylation/drug effects , rac1 GTP-Binding Protein/chemistry , rho GTP-Binding Proteins/chemistry , rho-Specific Guanine Nucleotide Dissociation Inhibitors/chemistry , Amino Acid Sequence/genetics , Guanine Nucleotide Dissociation Inhibitors/chemistry , Guanine Nucleotide Dissociation Inhibitors/pharmacology , Humans , Hydrophobic and Hydrophilic Interactions/drug effects , Kinetics , Static Electricity , rac1 GTP-Binding Protein/genetics , rho GTP-Binding Proteins/genetics , rho-Specific Guanine Nucleotide Dissociation Inhibitors/genetics
2.
Mol Biosyst ; 9(10): 2454-62, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23872884

ABSTRACT

A network of the Rho family GTPases, which cycle between inactive GDP-bound and active GTP-bound states, controls key cellular processes, including proliferation and migration. Activating and deactivating GTPase transitions are controlled by guanine nucleotide exchange factors (GEFs), GTPase activating proteins (GAPs) and GDP dissociation inhibitors (GDIs) that sequester GTPases from the membrane to the cytoplasm. Here we show that a cascade of two Rho family GTPases, RhoA and Rac1, regulated by RhoGDI1, exhibits distinct modes of the dynamic behavior, including abrupt, bistable switches, excitable overshoot transitions and oscillations. The RhoGDI1 abundance and signal-induced changes in the RhoGDI1 affinity for GTPases control these different dynamics, enabling transitions from a single stable steady state to bistability, to excitable pulses and to sustained oscillations of GTPase activities. These RhoGDI1-controlled dynamic modes of RhoA and Rac1 activities form the basis of cell migration behaviors, including protrusion-retraction cycles at the leading edge of migrating cells.


Subject(s)
Guanine Nucleotide Dissociation Inhibitors/chemistry , Monomeric GTP-Binding Proteins/chemistry , Enzyme Activation , GTP Phosphohydrolases/chemistry , GTP Phosphohydrolases/metabolism , Guanine Nucleotide Dissociation Inhibitors/metabolism , Guanine Nucleotide Dissociation Inhibitors/pharmacology , Kinetics , Models, Biological , Monomeric GTP-Binding Proteins/metabolism , Protein Binding/drug effects , rac1 GTP-Binding Protein/chemistry , rac1 GTP-Binding Protein/metabolism , rhoA GTP-Binding Protein/chemistry , rhoA GTP-Binding Protein/metabolism
3.
Eur J Oral Sci ; 117(3): 224-30, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19583748

ABSTRACT

Small GTP-binding protein, Rab27, has been implicated in the regulation of different types of membrane trafficking, including melanosome transport in melanocytes and regulated secretion events in a wide variety of secretory cells. We have previously shown that Rab27 is involved in the control of isoproterenol (IPR)-induced amylase release from rat parotid acinar cells. Although Rab27 is predominantly localized on secretory granules under resting conditions, changes to its intracellular localization after beta-stimulation have never been elucidated. The present study investigated IPR-induced redistribution of Rab27B in the parotid acinar cells, revealing translocation from secretory granules to the subapical region after 5 min of IPR treatment and then diffusion into the cytosol after 30 min of IPR treatment. Dissociation of Rab27B from the apical plasma membrane is probably mediated through the Rab GDP dissociation inhibitor (GDI) in the cytosol extracting GDP-bound Rab protein from membranes, as a dramatic increase in the amount of the Rab27B-GDI complex in the cytosol was observed 30 min after stimulation with IPR. These results indicate that, in parotid acinar cells, Rab27B is translocated, in a time-dependent manner, from secretory granules into the apical plasma membrane as a result of exposure to IPR, and then into the cytosol through binding with the GDI.


Subject(s)
Adrenergic beta-Agonists/pharmacology , Isoproterenol/pharmacology , Parotid Gland/drug effects , rab GTP-Binding Proteins/drug effects , Amylases/analysis , Animals , Biomarkers/analysis , Cell Membrane/drug effects , Cell Membrane/enzymology , Cells, Cultured , Cytosol/drug effects , Cytosol/enzymology , Guanine Nucleotide Dissociation Inhibitors/pharmacology , Parotid Gland/cytology , Parotid Gland/enzymology , Rats , Secretory Vesicles/drug effects , Secretory Vesicles/enzymology , Time Factors , Vesicle-Associated Membrane Protein 2/analysis , rab GTP-Binding Proteins/pharmacokinetics
4.
J Biol Chem ; 284(35): 23860-71, 2009 Aug 28.
Article in English | MEDLINE | ID: mdl-19581296

ABSTRACT

The subcellular localization of the Rho family GTPases is of fundamental importance to their proper functioning in cells. The Rho guanine nucleotide dissociation inhibitor (RhoGDI) plays a key regulatory role by influencing the cellular localization of Rho GTPases and is essential for the transforming activity of oncogenic forms of Cdc42. However, the mechanism by which RhoGDI helps Cdc42 to undergo the transition between a membrane-associated protein and a soluble (cytosolic) species has been poorly understood. Here, we examine how RhoGDI influences the binding of Cdc42 to lipid bilayers. Despite having similar affinities for the signaling-inactive (GDP-bound) and signaling-active (GTP-bound) forms of Cdc42 in solution, we show that when RhoGDI interacts with Cdc42 along the membrane surface, it has a much higher affinity for GDP-bound Cdc42 compared with its GTP-bound counterpart. Interestingly, the rate for the dissociation of Cdc42.RhoGDI complexes from membranes is unaffected by the nucleotide-bound state of Cdc42. Moreover, the membrane release of Cdc42.RhoGDI complexes occurs at a similar rate as the release of Cdc42 alone, with the major effect of RhoGDI being to impede the re-association of Cdc42 with membranes. These findings lead us to propose a new model for how RhoGDI influences the ability of Cdc42 to move between membranes and the cytosol, which highlights the role of the membrane in helping RhoGDI to distinguish between the GDP- and GTP-bound forms of Cdc42 and holds important implications for how it functions as a key regulator of the cellular localization and signaling activities of this GTPase.


Subject(s)
Cell Membrane/metabolism , Guanine Nucleotide Dissociation Inhibitors/pharmacology , cdc42 GTP-Binding Protein/metabolism , Animals , Cell Membrane/chemistry , Cytosol/chemistry , Cytosol/metabolism , Guanine Nucleotide Dissociation Inhibitors/chemistry , Guanosine Diphosphate/metabolism , Guanosine Triphosphate/metabolism , Kinetics , Protein Binding/drug effects , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , cdc42 GTP-Binding Protein/chemistry , cdc42 GTP-Binding Protein/genetics , rho-Specific Guanine Nucleotide Dissociation Inhibitors
5.
Chem Biol ; 15(1): 70-7, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18215774

ABSTRACT

Cryptosporidium parvum is an important human pathogen and potential bioterrorism agent. No vaccines exist against C. parvum, the drugs currently approved to treat cryptosporidiosis are ineffective, and drug discovery is challenging because the parasite cannot be maintained continuously in cell culture. Mining the sequence of the C. parvum genome has revealed that the only route to guanine nucleotides is via inosine-5'-monophosphate dehydrogenase (IMPDH). Moreover, phylogenetic analysis suggests that the IMPDH gene was obtained from bacteria by lateral gene transfer. Here we exploit the unexpected evolutionary divergence of parasite and host enzymes by designing a high-throughput screen to target the most diverged portion of the IMPDH active site. We have identified four parasite-selective IMPDH inhibitors that display antiparasitic activity with greater potency than paromomycin, the current gold standard for anticryptosporidial activity.


Subject(s)
Antiparasitic Agents/therapeutic use , Cryptosporidiosis/drug therapy , Cryptosporidium parvum/drug effects , Eukaryotic Cells/enzymology , IMP Dehydrogenase/antagonists & inhibitors , Prokaryotic Cells/enzymology , Animals , Antiparasitic Agents/chemistry , Antiparasitic Agents/pharmacology , Binding Sites , Cryptosporidiosis/enzymology , Cryptosporidium parvum/enzymology , Cryptosporidium parvum/pathogenicity , Guanine Nucleotide Dissociation Inhibitors/chemistry , Guanine Nucleotide Dissociation Inhibitors/pharmacology , Guanine Nucleotide Dissociation Inhibitors/therapeutic use , Guanine Nucleotides/metabolism , Humans , IMP Dehydrogenase/chemistry , IMP Dehydrogenase/metabolism , Kinetics , Paromomycin/chemistry , Paromomycin/pharmacology , Paromomycin/therapeutic use
6.
Methods Enzymol ; 407: 575-97, 2006.
Article in English | MEDLINE | ID: mdl-16757354

ABSTRACT

The proper subcellular localization and biological activity of most Ras and Rho family small GTPases are dependent on their posttranslational modification by isoprenylation. Farnesyltransferase (FTase) and geranylgeranyl transferase I (GGTase I) are the prenyltransferases that catalyze the irreversible attachment of C15 farnesyl (Ras, Rnd) or C20 (R-Ras, Ral, Rap, Rho, Rac, Cdc42) isoprenoid lipid moieties to these small GTPases and other proteins. Therefore, pharmacological inhibitors of FTase (FTIs) and GGTase I (GGTIs) have been developed to prevent these modifications and thereby to block the lipid-mediated association of Ras and Rho proteins with cellular membranes and the consequent signaling and transforming activities. In addition, other small molecule inhibitors such as farnesyl thiosalicylic acid (FTS) can compete with the isoprenoid moiety of small GTPases for membrane binding sites. Finally, endogenous regulatory proteins such as RhoGDIs can bind to and mask the prenyl groups of small GTPases, leading to their sequestration from membranes. We describe here methods to use each of these categories of prenylation inhibitors to manipulate and investigate the subcellular localization patterns and transforming potential of these Ras and Rho family GTPases.


Subject(s)
Enzyme Inhibitors/pharmacology , Prenylation/drug effects , Alkyl and Aryl Transferases/antagonists & inhibitors , Animals , Dimethylallyltranstransferase/antagonists & inhibitors , Farnesol/analogs & derivatives , Farnesol/pharmacology , Farnesyltranstransferase/antagonists & inhibitors , GTP Phosphohydrolases/antagonists & inhibitors , Guanine Nucleotide Dissociation Inhibitors/pharmacology , Mice , NIH 3T3 Cells , Protein Transport/drug effects , Salicylates/pharmacology , ras Proteins/antagonists & inhibitors , rho GTP-Binding Proteins/antagonists & inhibitors , rho-Specific Guanine Nucleotide Dissociation Inhibitors
8.
Nat Chem Biol ; 2(1): 39-46, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16408091

ABSTRACT

Inspired by the usefulness of small molecules to study membrane traffic, we used high-throughput synthesis and phenotypic screening to discover secramine, a molecule that inhibits membrane traffic out of the Golgi apparatus by an unknown mechanism. We report here that secramine inhibits activation of the Rho GTPase Cdc42, a protein involved in membrane traffic, by a mechanism dependent upon the guanine dissociation inhibitor RhoGDI. RhoGDI binds Cdc42 and antagonizes its membrane association, nucleotide exchange and effector binding. In vitro, secramine inhibits Cdc42 binding to membranes, GTP and effectors in a RhoGDI-dependent manner. In cells, secramine mimics the effects of dominant-negative Cdc42 expression on protein export from the Golgi and on Golgi polarization in migrating cells. RhoGDI-dependent Cdc42 inhibition by secramine illustrates a new way to inhibit Rho GTPases with small molecules and provides a new means to study Cdc42, RhoGDI and the cellular processes they mediate.


Subject(s)
Actins/metabolism , Benzazepines/pharmacology , Golgi Apparatus/drug effects , Guanine Nucleotide Dissociation Inhibitors/pharmacology , Oximes/pharmacology , cdc42 GTP-Binding Protein/antagonists & inhibitors , Animals , Benzazepines/chemical synthesis , Cattle , Cell Cycle Proteins/metabolism , Cell Membrane/metabolism , Dose-Response Relationship, Drug , GTPase-Activating Proteins/metabolism , Golgi Apparatus/metabolism , Guanine Nucleotide Dissociation Inhibitors/chemical synthesis , Oximes/chemical synthesis , Time Factors , cdc42 GTP-Binding Protein/metabolism , rho-Specific Guanine Nucleotide Dissociation Inhibitors
9.
J Cell Biol ; 168(3): 401-14, 2005 Jan 31.
Article in English | MEDLINE | ID: mdl-15684030

ABSTRACT

The regulation of cellular membrane flux is poorly understood. Yeast respond to hypertonic stress by fragmentation of the normally large, low copy vacuole. We used this phenomenon as the basis for an in vivo screen to identify regulators of vacuole membrane dynamics. We report here that maintenance of the fragmented phenotype requires the vacuolar casein kinase I Yck3: when Yck3 is absent, salt-stressed vacuoles undergo fission, but reassemble in a SNARE-dependent manner, suggesting that vacuole fusion is disregulated. Accordingly, when Yck3 is deleted, in vitro vacuole fusion is increased, and Yck3 overexpression blocks fusion. Morphological and functional studies show that Yck3 modulates the Rab/homotypic fusion and vacuole protein sorting complex (HOPS)-dependent tethering stage of vacuole fusion. Intriguingly, Yck3 mediates phosphorylation of the HOPS subunit Vps41, a bi-functional protein involved in both budding and fusion during vacuole biogenesis. Because Yck3 also promotes efficient vacuole inheritance, we propose that tethering complex phosphorylation is a part of a general, switch-like mechanism for driving changes in organelle architecture.


Subject(s)
Casein Kinase I/physiology , Saccharomyces cerevisiae Proteins/physiology , Saccharomyces cerevisiae/physiology , Vacuoles/physiology , Vesicular Transport Proteins/physiology , Adaptor Proteins, Vesicular Transport , Antibodies/pharmacology , Casein Kinase I/genetics , Casein Kinase I/metabolism , Enzyme Inhibitors/pharmacology , Genotype , Guanine Nucleotide Dissociation Inhibitors/pharmacology , Marine Toxins , Membrane Fusion/drug effects , Membrane Fusion/physiology , Membrane Proteins/immunology , Membrane Proteins/metabolism , Microcystins , Microscopy, Fluorescence , Models, Biological , Mutation , Nerve Tissue Proteins/immunology , Organelles/metabolism , Organelles/physiology , Peptides, Cyclic/pharmacology , Phosphorylation , Phosphotransferases (Alcohol Group Acceptor)/genetics , SNARE Proteins , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/agonists , Saccharomyces cerevisiae Proteins/antagonists & inhibitors , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/immunology , Saccharomyces cerevisiae Proteins/metabolism , Saline Solution, Hypertonic/pharmacology , Synaptosomal-Associated Protein 25 , Vacuoles/metabolism , Vesicular Transport Proteins/genetics , Vesicular Transport Proteins/immunology , Vesicular Transport Proteins/metabolism , rab GTP-Binding Proteins/antagonists & inhibitors , rab GTP-Binding Proteins/immunology , ras GTPase-Activating Proteins/agonists
10.
Biochem Biophys Res Commun ; 312(3): 663-9, 2003 Dec 19.
Article in English | MEDLINE | ID: mdl-14680816

ABSTRACT

Rab GTPases are key regulators of vesicular protein transport in both the endocytic and exocytic pathways. In endocytosis and recycling, Rab11 plays a role in receptor recycling to plasma membrane via the pericentriolar recycling compartment. However, little is known about the molecular requirements and partners that promote transport through Rab11-positive recycling endosomes. Here, we report a novel approach to reconstitute transport to immunoabsorbed recycling endosomes in vitro. We show that transport is temperature-, energy-, and time-dependent and requires the presence of Rab proteins, as it is inhibited by the Rab-interacting protein Rab GDP-dissociation inhibitor that removes Rab proteins from the membrane. Cytochalasin D, a drug that blocks actin polymerization, inhibits the in vitro assay, suggesting that transport to recycling endosomes depends on an intact actin cytoskeleton. Using an affinity chromatography approach we show the identification of Rab11-interacting proteins including actin that stimulate transport to recycling endosomes in vitro.


Subject(s)
Endosomes/metabolism , Protein Transport/physiology , Receptors, Transferrin/metabolism , Transport Vesicles/metabolism , Vesicular Transport Proteins/metabolism , rab GTP-Binding Proteins/metabolism , Adaptation, Physiological/drug effects , Adaptation, Physiological/physiology , Animals , CHO Cells , Cricetinae , Cricetulus , Cytochalasin D/pharmacology , Endosomes/drug effects , Guanine Nucleotide Dissociation Inhibitors/pharmacology , Protein Transport/drug effects , Transport Vesicles/drug effects
12.
EMBO J ; 21(6): 1289-300, 2002 Mar 15.
Article in English | MEDLINE | ID: mdl-11889035

ABSTRACT

We report that lipids contribute to regulate the bidirectional motility of late endocytic compartments. Late endocytic vesicles loaded with cholesterol lose their dynamic properties, and become essentially immobile, including in cells from Niemann-Pick C patients. These vesicles then retain cytoplasmic dynein activity, but seem to be unable to acquire kinesin activity, eventually leading to paralysis. Our data suggest that this defect depends on the small GTPase Rab7, since the motility of vesicles loaded with cholesterol can be restored by the Rab7 inhibitory mutant N125I. Conversely, wild-type Rab7 overexpression mimics the effects of cholesterol on motility in control cells. Consistently, cholesterol accumulation increases the amounts of membrane-associated Rab7, and inhibits Rab7 membrane extraction by the guanine nucleotide dissociation inhibitor. Our observations thus indicate that cholesterol contributes to regulate the Rab7 cycle, and that Rab7 in turn controls the net movement of late endocytic elements. We conclude that motor functions can be regulated by the membrane lipid composition via the Rab7 cycle.


Subject(s)
Cholesterol/metabolism , rab GTP-Binding Proteins/metabolism , Androstenes/pharmacology , Animals , Anticholesteremic Agents/pharmacology , Antigens, CD/genetics , Antigens, CD/metabolism , Cell Compartmentation , Cell Line , Cricetinae , Dynactin Complex , Endocytosis , Endosomes/metabolism , Green Fluorescent Proteins , Guanine Nucleotide Dissociation Inhibitors/pharmacology , HeLa Cells , Humans , Kinesins/genetics , Kinesins/metabolism , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Lysophospholipids/metabolism , Microtubule-Associated Proteins/metabolism , Microtubules/metabolism , Monoglycerides , Niemann-Pick Diseases/metabolism , Platelet Membrane Glycoproteins/genetics , Platelet Membrane Glycoproteins/metabolism , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Tetraspanin 30 , rab7 GTP-Binding Proteins
13.
EMBO J ; 20(20): 5650-6, 2001 Oct 15.
Article in English | MEDLINE | ID: mdl-11598008

ABSTRACT

Rho GTPases, which control polarized cell growth through cytoskeletal reorganization, have recently been implicated in the control of endo- and exocytosis. We now report that both Rho1p and Cdc42p have a direct role in mediating the docking stage of homotypic vacuole fusion. Vacuoles prepared from strains with temperature-sensitive alleles of either Rho1p or Cdc42p are thermolabile for fusion. RhoGDI (Rdi1p), which extracts Rho1p and Cdc42p from the vacuole membrane, blocks vacuole fusion. The Rho GTPases can not fulfill their function as long as priming and Ypt7p-dependent tethering are inhibited. However, reactions that are reversibly blocked after docking by the calcium chelator BAPTA have passed the point of sensitivity to Rdi1p. Extraction and removal of Ypt7p, Rho1p and Cdc42p from docked vacuoles (by Gdi1p, Gyp7p and Rdi1p) does not impede subsequent membrane fusion, which is still sensitive to GTPgammaS. Thus, multiple GTPases act in a defined sequence to regulate the docking steps of vacuole fusion.


Subject(s)
Egtazic Acid/analogs & derivatives , Fungal Proteins/physiology , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/metabolism , Vacuoles/physiology , cdc42 GTP-Binding Protein, Saccharomyces cerevisiae/physiology , rab GTP-Binding Proteins/physiology , rho GTP-Binding Proteins/physiology , Alleles , Chelating Agents/pharmacology , Egtazic Acid/pharmacology , Fungal Proteins/genetics , Guanine Nucleotide Dissociation Inhibitors/pharmacology , Guanosine 5'-O-(3-Thiotriphosphate)/pharmacology , Kinetics , Macromolecular Substances , Membrane Fusion , Protein Transport , Recombinant Fusion Proteins/physiology , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/ultrastructure , cdc42 GTP-Binding Protein, Saccharomyces cerevisiae/genetics , rab GTP-Binding Proteins/genetics , ras GTPase-Activating Proteins/pharmacology , rho GTP-Binding Proteins/genetics , rho-Specific Guanine Nucleotide Dissociation Inhibitors
14.
Biochem Biophys Res Commun ; 280(4): 970-5, 2001 Feb 02.
Article in English | MEDLINE | ID: mdl-11162620

ABSTRACT

Platelets play essential roles in hemostasis and thrombosis by aggregating with each other. However, the molecular mechanism governing platelet aggregation is not yet fully understood. Here, we established an assay system using platelets permeabilized with streptolysin-O to analyze mechanism of the thrombin-induced aggregation, focusing upon a controversial issue in the field whether small GTPase Rho regulates the aggregation. Incubation of the permeabilized platelets with Rho GDP-dissociation inhibitor, an inhibitory regulator for Rho family GTPases, extracted Rho family proteins extensively from the plasma and intracellular membranes, and inhibited the thrombin-induced aggregation. Incubation of the permeabilized platelets with botulinum exoenzyme C3, which specifically inhibits Rho function by ADP-ribosylating it, abolished the thrombin-induced aggregation. Thus, Rho is involved in thrombin-induced aggregation of platelets.


Subject(s)
Botulinum Toxins , Platelet Aggregation/physiology , Thrombin/metabolism , rho GTP-Binding Proteins/physiology , ADP Ribose Transferases/pharmacology , Amides/pharmacology , Bacterial Proteins , Blood Platelets/drug effects , Blood Platelets/metabolism , Cell Membrane/enzymology , Cell Membrane/metabolism , Cytosol/metabolism , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Escherichia coli/metabolism , Glutathione Transferase/metabolism , Guanine Nucleotide Dissociation Inhibitors/pharmacology , HEPES/pharmacology , Humans , Platelet Aggregation/drug effects , Poly(ADP-ribose) Polymerases/metabolism , Pyridines/pharmacology , Signal Transduction/drug effects , Streptolysins/metabolism , Thrombin/pharmacology , Time Factors , rho-Specific Guanine Nucleotide Dissociation Inhibitors
15.
J Cell Biol ; 148(4): 741-53, 2000 Feb 21.
Article in English | MEDLINE | ID: mdl-10684255

ABSTRACT

To understand intracellular trafficking modulations by live Salmonella, we investigated the characteristics of in vitro fusion between endosomes and phagosomes containing live (LSP) or dead Salmonella (DSP). We observed that fusion of both DSP and LSP were time, temperature and cytosol dependent. GTPgammaS and treatment of the phagosomes with Rab-GDI inhibited fusion, indicating involvement of Rab-GTPases. LSP were rich in rab5, alpha-SNAP, and NSF, while DSP mainly contained rab7. Fusion of endosomes with DSP was inhibited by ATP depletion, N-ethylmaleimide (NEM) treatment, and in NEM-sensitive factor (NSF)-depleted cytosol. In contrast, fusion of endosomes with LSP was not inhibited by ATP depletion or NEM treatment, and occurred in NSF-depleted cytosol. However, ATPgammaS inhibited both fusion events. Fusion of NEM-treated LSP with endosomes was abrogated in NSF- depleted cytosol and was restored by adding purified NSF, whereas no fusion occurred with NEM-treated DSP, indicating that NSF recruitment is dependent on continuous signals from live Salmonella. Binding of NSF with LSP required prior presence of rab5 on the phagosome. We have also shown that rab5 specifically binds with Sop E, a protein from Salmonella. Our results indicate that live Salmonella help binding of rab5 on the phagosomes, possibly activate the SNARE which leads to further recruitment of alpha-SNAP for subsequent binding with NSF to promote fusion of the LSP with early endosomes and inhibition of their transport to lysosomes.


Subject(s)
Carrier Proteins/metabolism , Endosomes/metabolism , Ethylmaleimide/pharmacology , Macrophages/cytology , Membrane Fusion , Phagosomes/metabolism , Salmonella/metabolism , Vesicular Transport Proteins , Adenosine Triphosphate/metabolism , Animals , Anti-Infective Agents/pharmacology , Bacterial Proteins/metabolism , Carrier Proteins/antagonists & inhibitors , Cell Line , Ciprofloxacin/pharmacology , Cytosol/chemistry , Cytosol/drug effects , Cytosol/metabolism , Endosomes/drug effects , Guanine Nucleotide Dissociation Inhibitors/pharmacology , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , Guanosine Diphosphate/metabolism , Guanosine Diphosphate/pharmacology , Intracellular Membranes/drug effects , Intracellular Membranes/metabolism , Macrophages/drug effects , Macrophages/microbiology , Membrane Fusion/drug effects , Membrane Proteins/metabolism , Mice , Mutation/genetics , N-Ethylmaleimide-Sensitive Proteins , Phagosomes/drug effects , Receptors, Transferrin/metabolism , Recombinant Fusion Proteins/antagonists & inhibitors , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Salmonella/cytology , Salmonella/drug effects , Salmonella/genetics , Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins , Temperature , rab5 GTP-Binding Proteins/antagonists & inhibitors , rab5 GTP-Binding Proteins/genetics , rab5 GTP-Binding Proteins/metabolism
16.
J Biol Chem ; 275(6): 3745-8, 2000 Feb 11.
Article in English | MEDLINE | ID: mdl-10660521

ABSTRACT

The molecular mechanisms ensuring directionality of endocytic membrane trafficking between transport vesicles and target organelles still remain poorly characterized. We have been investigating the function of the small GTPase Rab5 in early endocytic transport. In vitro studies have demonstrated a role of Rab5 in two membrane fusion events: the heterotypic fusion between plasma membrane-derived clathrin-coated vesicles (CCVs) and early endosomes and in the homotypic fusion between early endosomes. Several Rab5 effectors are required in homotypic endosome fusion, including EEA1, which mediates endosome membrane docking, as well as Rabaptin-5 x Rabex-5 complex and phosphatidylinositol 3-kinase hVPS34. In this study we have examined the localization and function of Rab5 and its effectors in heterotypic fusion in vitro. We report that the presence of active Rab5 is necessary on both CCVs and early endosomes for a heterotypic fusion event to occur. This process requires EEA1 in addition to the Rabaptin-5 complex. However, whereas Rab5 and Rabaptin-5 are symmetrically distributed between CCVs and early endosomes, EEA1 is recruited selectively onto the membrane of early endosomes. Our results suggest that EEA1 is a tethering molecule that provides directionality to vesicular transport from the plasma membrane to the early endosomes.


Subject(s)
Clathrin/metabolism , Endocytosis , Endosomes/metabolism , Membrane Proteins/metabolism , Vesicular Transport Proteins , Guanine Nucleotide Dissociation Inhibitors/pharmacology , HeLa Cells , Humans , Membrane Fusion/drug effects , rab5 GTP-Binding Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...